Clinical research of pulmonary rehabilitation in survivors due to severe or critial novel coronavirus pneumonia (COVID-19)

Effect of pulmonary rehabilitation on pulmonary function, exercise capacity, activity of daily living and quality of life in survivors due to severe or critial novel coronavirus pneumonia (COVID-19)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030198

Enrollment

Unknown

Registered

2020-02-25

Start date

2020-02-24

Completion date

Unknown

Last updated

2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

experimental group:Health education+ pulmonary rehabilitation

control group:Health educatio

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients discharged from severe or critical new coronavirus pneumonia; 2. Adults over 18 years of age who signed the informed consent; 3. Study participants are willing to accept random assignment to any designated treatment group; 4. Prior to the completion of this study, participants must agree not to participate in another study.

Exclusion criteria

Exclusion criteria: 1. Pneumonia caused by other reasons; 2. Have contraindications that can not participate in sports activities; 3. Mental disorders, cognitive impairments etc. can not cooperate with researchers subjectively.

Design outcomes

Primary

Measure	Time frame
pulmonary function;	—

Secondary

Measure	Time frame
6-minute walk test;basic ADL;IADL;anxiety;depression;quality of life;	—

Countries

China

Contacts

Public ContactChengqi He

West China Hospital, Sichuan University

hxkfhcq@126.com+86 18980601618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026